[Management of patients with essential thrombocythemia].

Suppr

超能文献

作者信息

Ramirez Gemma, García-Sanchez Ricarda, Plaza Sylvia

机构信息

Servicio de Hematología y Hemoterapia, Hospital Virgen de la Victoria, Málaga, España.

出版信息

Med Clin (Barc). 2013 Mar 16;140(6):278-82. doi: 10.1016/j.medcli.2012.10.007. Epub 2012 Nov 21.

DOI:10.1016/j.medcli.2012.10.007

PMID:23177312

Abstract

摘要

相似文献

[Management of patients with essential thrombocythemia].

Med Clin (Barc). 2013 Mar 16;140(6):278-82. doi: 10.1016/j.medcli.2012.10.007. Epub 2012 Nov 21.

[Treatment of essential thrombocythemia].

Med Clin (Barc). 2013 Sep 21;141(6):260-4. doi: 10.1016/j.medcli.2013.01.016. Epub 2013 Mar 13.

Pathogenesis and management of essential thrombocythemia.

Hematology Am Soc Hematol Educ Program. 2009:621-8. doi: 10.1182/asheducation-2009.1.621.

Is anagrelide safe during pregnancy?

J Gynecol Obstet Hum Reprod. 2017 Nov;46(9):697-699. doi: 10.1016/j.jogoh.2017.08.005. Epub 2017 Sep 1.

Essential thrombocythaemia.

Hematology. 2015 Mar;20(2):119-20. doi: 10.1179/1024533215Z.000000000349.

Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.

Am J Hematol. 2009 Apr;84(4):215-20. doi: 10.1002/ajh.21360.

Anagrelide treatment in early pregnancy in a patient with JAK2V617F-positive essential thrombocythemia: case report and literature review.

Acta Haematol. 2009;122(4):221-2. doi: 10.1159/000253030. Epub 2009 Oct 29.

Management of the myeloproliferative disorders : distinguishing data from dogma.

Hematol J. 2004;5 Suppl 3:S126-32. doi: 10.1038/sj.thj.6200438.

Primary thrombocythemia: new drugs for an evolving disease.

Haematologica. 1992 Jul-Aug;77(4):297-301.

Dysplasia of all granulocyte lineages in myelodysplastic evolution of essential thrombocythemia.

Am J Hematol. 2013 May;88(5):426. doi: 10.1002/ajh.23395. Epub 2013 Mar 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Management of patients with essential thrombocythemia].

Med Clin (Barc). 2013 Mar 16;140(6):278-82. doi: 10.1016/j.medcli.2012.10.007. Epub 2012 Nov 21.

[Treatment of essential thrombocythemia].

Med Clin (Barc). 2013 Sep 21;141(6):260-4. doi: 10.1016/j.medcli.2013.01.016. Epub 2013 Mar 13.

Pathogenesis and management of essential thrombocythemia.

Hematology Am Soc Hematol Educ Program. 2009:621-8. doi: 10.1182/asheducation-2009.1.621.

Is anagrelide safe during pregnancy?

J Gynecol Obstet Hum Reprod. 2017 Nov;46(9):697-699. doi: 10.1016/j.jogoh.2017.08.005. Epub 2017 Sep 1.

Essential thrombocythaemia.

Hematology. 2015 Mar;20(2):119-20. doi: 10.1179/1024533215Z.000000000349.

Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.

Am J Hematol. 2009 Apr;84(4):215-20. doi: 10.1002/ajh.21360.

Anagrelide treatment in early pregnancy in a patient with JAK2V617F-positive essential thrombocythemia: case report and literature review.

Acta Haematol. 2009;122(4):221-2. doi: 10.1159/000253030. Epub 2009 Oct 29.

Management of the myeloproliferative disorders : distinguishing data from dogma.

Hematol J. 2004;5 Suppl 3:S126-32. doi: 10.1038/sj.thj.6200438.

Primary thrombocythemia: new drugs for an evolving disease.

Haematologica. 1992 Jul-Aug;77(4):297-301.

Dysplasia of all granulocyte lineages in myelodysplastic evolution of essential thrombocythemia.

Am J Hematol. 2013 May;88(5):426. doi: 10.1002/ajh.23395. Epub 2013 Mar 5.